ERBB2 and gastric cancer: Therefore, in this review, we summarize the PK disposition of several molecules (e.g., anti‐HER2, anti‐VEGF, and anti‐PD1) evaluated in GC and showed a consistent trend of lower drug exposure as compared to other solid tumors.